- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Brainsway Ltd (BWAY)
Brainsway Ltd stock price live, this page displays NASDAQ BWAY stock exchange data. View the BWAY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Brainsway Ltd real time stock price chart below.
What Is the Brainsway Ltd Stock Price Today?
The Brainsway Ltd stock price today is 10.25.
What Is the Stock Symbol for Brainsway Ltd?
The stock symbol for Brainsway Ltd is "BWAY."
What Stock Exchange Does Brainsway Ltd Trade On?
Brainsway Ltd is listed and trades on the NASDAQ stock exchange.
Is Brainsway Ltd a Good Stock to Buy?
Determining whether Brainsway Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BWAY quote. (ISIN: US10501L1061)
What Is the Brainsway Ltd Stock Price Today?
The Brainsway Ltd stock price today is 10.25.
What Is the Stock Symbol for Brainsway Ltd?
The stock symbol for Brainsway Ltd is "BWAY."
What Stock Exchange Does Brainsway Ltd Trade On?
Brainsway Ltd is listed and trades on the NASDAQ stock exchange.
Is Brainsway Ltd a Good Stock to Buy?
Determining whether Brainsway Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BWAY quote. (ISIN: US10501L1061)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.20
10.95
52 wk Range
7.14
17.40
BWAY is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.2010.95
52 wk Range
7.1417.40
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BWAY Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
19.27
Upside
+87.97%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 19.27
(+87.97% Upside)
Brainsway Ltd Earnings Call Summary for Q3/2026
- Q3 revenue rose 34% YoY to $18.1M, beating estimates by 1.69%; EPS of $0.05 missed forecast of $0.09 by 44.44%, triggering 6.53% stock decline.
- Gross margin expanded to 78% from 75%; operating income surged 107% to $2.6M; adjusted EBITDA nearly doubled to $3.9M on improved profitability.
- Management expects FY 2026 results at upper end of guidance; projects 2027 opex growth of 15-20%, below revenue growth, supporting margin expansion.
- CEO Levy highlighted shift to neurostimulation platform model; SWIFT protocol drives 50% of new demand; book-to-bill ratio at 1.3x-1.4x signals visibility.
- Growth drivers include SWIFT adoption, broader reimbursement, OCD/depression systems, Japan expansion, and behavioral health partnerships with $85M backlog.
Last Updated: 11/10/2026, 10:58 PM
Read Full TranscriptEarnings
Latest Release
Nov 10, 2026
EPS / Forecast
0.05 / 0.09
Revenue / Forecast
18.1M / 17.8M
Compare BWAY to Peers and Sector
Metrics to compare | BWAY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBWAYPeersSector | |
|---|---|---|---|---|
P/E Ratio | 44.0x | −0.2x | −0.2x | |
PEG Ratio | 0.40 | −0.09 | 0.00 | |
Price/Book | 5.2x | 3.7x | 2.6x | |
Price / LTM Sales | 6.8x | 3.3x | 2.8x | |
Upside (Analyst Target) | 81.8% | 66.4% | 60.5% | |
Fair Value Upside | Unlock | 15.3% | 7.8% | Unlock |
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Brainsway (BWAY) Stock Price Today?
The Brainsway stock price today is 10.25 USD.
What Stock Exchange Does Brainsway Trade On?
Brainsway is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Brainsway?
The stock symbol for Brainsway is "BWAY."
What Is the Brainsway Market Cap?
As of today, Brainsway market cap is 434.94M USD.
What Is Brainsway's Earnings Per Share (TTM)?
The Brainsway EPS (TTM) is 0.24.
When Is the Next Brainsway Earnings Date?
Brainsway will release its next earnings report on Mar 17, 2027.
From a Technical Analysis Perspective, Is BWAY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Brainsway Stock Split?
Brainsway has split 1 times.
How Many Employees Does Brainsway Have?
Brainsway has 129 employees.
What is the current trading status of Brainsway (BWAY)?
As of Nov 12, 2026, Brainsway (BWAY) is trading at a price of 10.25 USD, with a previous close of 11.24 USD. The stock has fluctuated within a day range of 10.20 USD to 10.95 USD, while its 52-week range spans from 7.14 USD to 17.40 USD.
What Is Brainsway (BWAY) Price Target According to Analysts?
The average 12-month price target for Brainsway is 19.27 USD, with a high estimate of 20 USD and a low estimate of 18.8 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +87.97% Upside potential.
What Is the BWAY Premarket Price?
BWAY's last pre-market stock price is 10.65 USD. The pre-market share volume is 9,280.00, and the stock has decreased by -0.59, or -5.25%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.